[Deleted Court’s decision on Amphastar PI (already done).]
Lovenox
• 7-Nov-2011: MNTA’s 3Q11 financial results and CC, which will presumably provide additional color on matters relating to MNTA’s Lovenox franchise.
• 4-Feb-2013 (not a typo): Start of NVS/MNTA’s patent-infringement suit against Teva. (This suit is now much less consequential than MNTA’s suit against Amphastar.)
Copaxone
• Late 2011/early 2012: Court ruling on Copaxone patent trial.